First proposed in 2010 (1), anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is the second most common type of autoimmune encephalitis (2), accounting for about 12.8% in China (3). This evidence concerns the gene LGI1 and autoimmune encephalitis.